Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian E Mann

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Advances in Microbial Physiology|October 15, 2010
Carbon monoxide in biology and microbiology: surprising roles for the "Detroit perfume"Kelly S Davidge, Roberto Motterlini, Brian E Mann, et al.
British Journal of Pharmacology|May 10, 2005
Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophagesPhilip Sawle, Roberta Foresti, Brian E Mann, et al.
Antioxidants & Redox Signaling|March 12, 2013
Analysis of the bacterial response to Ru(CO)3Cl(Glycinate) (CORM-3) and the inactivated compound identifies the role played by the ruthenium compound and reveals sulfur-containing species as a major target of CORM-3 actionSamantha McLean, Ronald Begg, Helen E Jesse, et al.
Circulation Research|February 9, 2002
Carbon monoxide-releasing molecules: characterization of biochemical and vascular activitiesRoberto Motterlini, James E Clark, Roberta Foresti, et al.
Biochimica Et Biophysica Acta|April 30, 2013
Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respirationHelen E Jesse, Tacita L Nye, Samantha McLean, et al.
Angewandte Chemie (International Ed. in English)|August 19, 2003
Metal carbonyls: a new class of pharmaceuticals?Tony R Johnson, Brian E Mann, James E Clark, et al.
Journal of the American Chemical Society|August 29, 2002
Investigations by (13)C NMR spectroscopy of ethene-initiated catalytic CO hydrogenationMichael L Turner, Nyoman Marsih, Brian E Mann, et al.
Current Pharmaceutical Design|October 8, 2003
Bioactivity and pharmacological actions of carbon monoxide-releasing moleculesRoberto Motterlini, Brian E Mann, Tony R Johnson, et al.
Dalton Transactions (Cambridge, England : 2003)|July 16, 2011
A re-investigation of [Fe(L-cysteinate)2(CO)2]2-: an example of non-heme CO coordination of possible relevance to CO binding to ion channel receptorsLindsay Hewison, Tony R Johnson, Brian E Mann, et al.
Pharmacological Research|December 21, 2012
Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs)Roberto Motterlini, Philip Sawle, Jehad Hammad, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Advances in Microbial Physiology|October 15, 2010
Carbon monoxide in biology and microbiology: surprising roles for the "Detroit perfume"Kelly S Davidge, Roberto Motterlini, Brian E Mann, et al.
British Journal of Pharmacology|May 10, 2005
Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophagesPhilip Sawle, Roberta Foresti, Brian E Mann, et al.
Antioxidants & Redox Signaling|March 12, 2013
Analysis of the bacterial response to Ru(CO)3Cl(Glycinate) (CORM-3) and the inactivated compound identifies the role played by the ruthenium compound and reveals sulfur-containing species as a major target of CORM-3 actionSamantha McLean, Ronald Begg, Helen E Jesse, et al.
Circulation Research|February 9, 2002
Carbon monoxide-releasing molecules: characterization of biochemical and vascular activitiesRoberto Motterlini, James E Clark, Roberta Foresti, et al.
Biochimica Et Biophysica Acta|April 30, 2013
Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respirationHelen E Jesse, Tacita L Nye, Samantha McLean, et al.
Angewandte Chemie (International Ed. in English)|August 19, 2003
Metal carbonyls: a new class of pharmaceuticals?Tony R Johnson, Brian E Mann, James E Clark, et al.
Journal of the American Chemical Society|August 29, 2002
Investigations by (13)C NMR spectroscopy of ethene-initiated catalytic CO hydrogenationMichael L Turner, Nyoman Marsih, Brian E Mann, et al.
Current Pharmaceutical Design|October 8, 2003
Bioactivity and pharmacological actions of carbon monoxide-releasing moleculesRoberto Motterlini, Brian E Mann, Tony R Johnson, et al.
Dalton Transactions (Cambridge, England : 2003)|July 16, 2011
A re-investigation of [Fe(L-cysteinate)2(CO)2]2-: an example of non-heme CO coordination of possible relevance to CO binding to ion channel receptorsLindsay Hewison, Tony R Johnson, Brian E Mann, et al.
Pharmacological Research|December 21, 2012
Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs)Roberto Motterlini, Philip Sawle, Jehad Hammad, et al.
Pageof 4